Provided by Tiger Trade Technology Pte. Ltd.

PagerDuty, Inc.

13.55
-0.0300-0.22%
Volume:477.09K
Turnover:6.45M
Market Cap:1.07B
PE:6.67
High:13.68
Open:13.55
Low:13.38
Close:13.58
52wk High:16.91
52wk Low:5.70
Shares:78.65M
Float Shares:70.64M
Volume Ratio:0.37
T/O Rate:0.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.03
EPS(LYR):1.87
ROE:82.56%
ROA:2.29%
PB:4.59
PE(LYR):7.25

Loading ...

Shandong Boan Wins CDE Nod for Next-Gen PD-1/IL-2 Cancer Drug BA1203

TIPRANKS
·
Jul 08

Pagerduty Files Form 3 Beneficial Ownership Statement for CFO Eric Prengel

Reuters
·
Jul 07

ABBISKO-B Unit Enters Strategic Collaboration with AstraZeneca for Clinical Study on First-in-Class Oral PD-L1 Inhibitor Combined with Tagrisso in Non-Small Cell Lung Cancer

Stock News
·
Jul 02

Press Release: Annovis Appoints Cheng Fang, Ph.d., as Chief Scientific Officer

Dow Jones
·
Jul 01

Larimar Therapeutics Reports Positive Open Label Data and Submission of First Module of Rolling BLA for Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia

GlobeNewswire
·
Jun 29

Hengrui Wins Landmark NMPA Nod for New Lung Cancer Use of PD-L1 Drug

TIPRANKS
·
Jun 25

Analysts Offer Insights on Technology Companies: PagerDuty (PD), Zebra Tech (ZBRA) and Oracle (ORCL)

TIPRANKS
·
Jun 23

Analysts Have Conflicting Sentiments on These Technology Companies: PagerDuty (PD) and International Business Machines (IBM)

TIPRANKS
·
Jun 23

PagerDuty Names Eric Prengel as CFO

MT Newswires Live
·
Jun 23

PagerDuty names Eric Prengel as new CFO

TIPRANKS
·
Jun 23

PagerDuty shareholders elected four directors at annual meeting

Reuters
·
Jun 23

PagerDuty names Eric Prengel CFO as Howard Wilson retires

Reuters
·
Jun 23

PagerDuty Appoints Eric Prengel as Chief Financial Officer

THOMSON REUTERS
·
Jun 23

How Investors Are Reacting To Agilent Technologies (A) Expanding PD-L1 Test Use And Launching New AI Partnership

Simply Wall St.
·
Jun 16

ENDO 2026 Oral Presentation Highlights Comparative Clinical Data for Entera’s Breakthrough Single Tablet EB613 (First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis)

GlobeNewswire
·
Jun 15

Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)

GlobeNewswire
·
Jun 14

SIMCERE PHARMA Receives NMPA Approval for Clinical Trial of SIM0689, a Dual-Target Antibody

Stock News
·
Jun 12

Simcere Wins NMPA Green Light for PD-1/VEGF Bispecific Cancer Therapy

TIPRANKS
·
Jun 12

PagerDuty survey finds 66% of office professionals use unauthorized AI tools at work

Reuters
·
Jun 11

Press Release: AC Immune to Receive Research Grant from Goradia Family for Development of ACI-7104 in Parkinson's Disease

Dow Jones
·
Jun 11